INNMF
Amplia Therapeutics Limited
Set alert
0.05 USD 0.00 0.00%
0.0575 Day range 0.0575
0.05 52-week range 0.27
- YTD
- -31.65%
- 1 year
- +10.20%
- Open
- 0.0575
- Prev close
- 0.054
- Mkt cap
- 27.72M
- Vol
- 20.00K
- Avg vol
- 20.55K
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.0575
- High
- 0.0575
News
- Amplia Therapeutics partners with Lilly on lung cancer combination trial
- Amplia Signs Collaboration Agreement With Lilly, Evaluating Narmafotinib Plus Lilly's Kras G12C Inhibitor, Olomorasib, in Non-small Cell Lung Cancer
- Scientific Paper Detailing Preclinical Studies of Narmafotinib in Pancreatic Cancer Now Online
- Amplia Announces Publication of New FAK Inhibitor Patent Application
- Amplia Announces Appointment of Brett Carter to Board
- Amplia Announces Changes to Board's Leadership Roles
- Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer
- Amplia Therapeutics Launches First Stage of Registration-Enabling Trial of Narmafotinib
- Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
- Accent Trial Mature Data Presented at International Conference
Your note
Sign in to keep a note on INNMF — it syncs with the Stock Master app.